Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Sarcoma 1Gastrointestinal 1Dermatologic 1

Conditions

Anemia, Iron-Deficiency 2Anemia 2Plexosarcoma 1Neoplasms 1Melanoma 1Lymphoma, Follicular 1Gastrointestinal Stromal Tumors 1Crohn Disease 1Colitis, Ulcerative 1

Interventions

ferric carboxymaltose 2Iron-Dextran Complex 2iron isomaltoside 1000 1ferroglycine sulfate 1Surveys and Questionnaires 1Radiotherapy, Intensity-Modulated 1Niferex 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Anemia, Iron-Deficiency × Iron-Dextran Complex × Clear all
NCT06508827 2025-07-09

Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma

Indiana University

Phase 2 Withdrawn
Classical hematologyDermatologic

Anemia, Melanoma, Anemia, Iron-Deficiency

NCT02949947 2020-04-06

Efficacy of Ferric Carboxymaltose in Gastrointestinal Stromal Tumor (GIST) Patients With Iron Deficiency Anemia (IDA) Receiving Systemic Therapy

M.D. Anderson Cancer Center

Phase 2 Terminated
3 enrolled 5 charts
Classical hematologyGastrointestinalSarcoma

Plexosarcoma, Anemia, Iron-Deficiency, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡